Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Clasificación en acciones #24695
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Precio por acción
$0.95011029
Última sincronización: 2023-06-28
Capitalización bursátil
$57.72M
Cambio (1 día)
8.53%
Cambio (1 año)
0.00%
País
FR
Comercio ERYTECH Pharma S.A. (ERYP)

Categoría

Historial de desdoblamientos de acciones de ERYTECH Pharma S.A. (ERYP)
La acción ERYTECH Pharma S.A. (símbolo: ERYP) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 21, 2026.
Una acción ERYP comprada antes de Aug 21, 2026 equivaldría hoy a 0 acciones ERYP.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH